Week 355 Review - Another drop in the drip drip reduction in portfolio value

The positive weeks have been positive by a few hundred quid, whereas the negative weeks have been by a few thousand. This week the deficit between cost and value widened by £2,872 mainly thanks to a 1.5p drop in OPTI:Optibiotix, but most of my other large holdings dropped as well. The deficit is now a record £94,502 and the portfolio is only worth £86,578.

Biggest faller was JLP:Jubilee Metals which can't seem to hold any gains. It dropped 16% of my purchase price but is still up by 230%, although I don't have many left now.

SBTX:SkinBioTherapeutics dropped 6%. I think the fact that customers for the lysate were able to start trialling products in November but we've heard absolutely nothing about what's happening, added to the dismal launch of their psoriasis treatment means these will drift lower until there's news. I'm reasonably confident in their long term value though.

IQE:IQE climbed 5% but are many years away from ever breaking even at 71% down. I suspect they will go bust before I ever get back into profit on them.

SAE:Simec Atlantis Energy also climbed 5% but are still 69% down and their future is still dependent on government subsidy.

Share of the week is ASHM:Ashmore Group which climbed 7%. I don't know why, but I'm happy. They are still 16% down so my magic formula isn't very magic at the moment.

Bad

New lowest ever low. Will the torture ever stop?

Here's the ISA and shares portfolio after week 43 of year 7.

			Weekly Change
Cash	£6.43		+£0
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£38,007.75	(-54.2%)	-£1,619.71
Potential profits	£1,366.05		-£94.50
Yr 7 Dividends	£10,425.77		+£0
Yr 7 Profit from sales	£3,970.12		+£0
Yr 7 projected avg monthly profit	£1,447.35	(39.3%)	-£34.46
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£482.74	(13.1%)	-£1.36
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

Big drop in value and JLP:Jubilee Metals dropping £94 of potential profits.

Lowest ever low for the ISA

The SIPP looks like this after week 339 overall and week 27 of year 7.

			Weekly Change
Cash	£97.24		+£0
Portfolio cost	£95,431.30		+£0
Portfolio sell value (bid price - commission)	£47,461.95	(-50.3%)	-£1,271.01
Potential profits	£48.94		+£35.70
Yr 7 Dividends	£10,565.04		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£358.14		+£0
Yr 7 projected avg monthly profit	£1,737.21	(39.1%)	-£66.82
Total Dividends	£13,769.43		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£24,082.77		+£0
Average monthly cash profit	£472.08	(10.6%)	-£1.40
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	69%		-1%

Same story on the value, but this time potential profits are up £35 thanks to a revival in CAML:Central Asia Metals.

Not surprisingly also a record low for the SIPP

The trading account looks like this after week 305 overall and week 45 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£745.84	(-68.6%)	+£18.21
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£14.18	(7.2%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

Great news, the improvement in IQE:IQE was the main reason for the rise.

A slight creep upwards but way below injection line still

We've been above the trend line for ages now. Only a little bit, but it's the only ray of sunlight in my otherwise disastrous performance.

Roll on next week...